The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"I would have done anything to give birth...they could have asked me anything, and I would have almost certainly said yes, as long as it meant getting the baby out" - one participant's revelation from a study showing physical discomfort, not BMI concerns, drove women's choices for early induction.
Solid organ transplant recipients are at heightened risk for preeclampsia, preterm birth, and low birth weight during pregnancy, according to findings from a new study.